Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Eukaryotic Translation Initiation Factor 1A, X-Linked (EIF1AX) (Middle Region) Peptide

EIF1AX Hôte: Synthetic BP, WB
N° du produit ABIN8099907
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Eukaryotic Translation Initiation Factor 1A, X-Linked (EIF1AX) (Middle Region) Peptide (ABIN8099907)

Antigène

EIF1AX (Eukaryotic Translation Initiation Factor 1A, X-Linked (EIF1AX))

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Fonction

    EIF1AX Peptide - middle region
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-EIF1AX antibody ( ARP46055_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    EIF1AX (Eukaryotic Translation Initiation Factor 1A, X-Linked (EIF1AX))

    Sujet

    Background Information: This gene encodes an essential eukaryotic translation initiation factor. The protein is required for the binding of the 43S complex (a 40S subunit, eIF2/GTP/Met-tRNAi and eIF3) to the 5' end of capped RNA.

    Alternative Symbols: EIF1A, EIF4C, eIF-1A, eIF-4C, EIF1AP1

    Poids moléculaire

    16kDa

    ID gène

    1964

    NCBI Accession

    NP_001403

    UniProt

    P47813
Vous êtes ici:
Chat with us!